• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浓度-效应关系作为选择抗菌作用最佳终点的依据:达托霉素和万古霉素在体外动态模型中对葡萄球菌的药效学研究

Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.

作者信息

Smirnova Maria V, Lubenko Irene Yu, Portnoy Yury A, Zinner Stephen H, Firsov Alexander A

机构信息

Department of Pharmacokinetics and Pharmacodynamics, Gause Institute of New Antibiotics, Russian Academy of Medical Sciences, 11 Bolshaya Pirogovskaya Street, Moscow 119021, Russia.

出版信息

Int J Antimicrob Agents. 2007 Feb;29(2):165-9. doi: 10.1016/j.ijantimicag.2006.09.011. Epub 2007 Jan 4.

DOI:10.1016/j.ijantimicag.2006.09.011
PMID:17207607
Abstract

The abilities of different indices of bacterial killing to ensure reasonable concentration-response relationships have been compared only in studies in vitro with fluoroquinolones. To ascertain the relevance of conclusions drawn in these studies to other antibiotic classes, five widely used indices that reflect the rate of initial killing (time to reduce the initial inoculum 10- and 100-fold-T(90%) and T(99%), respectively), the extent of killing (minimal number of surviving organisms-N(min)), and the entire antimicrobial effect (number of surviving organisms (N(t)) at the time t close to the end of the observation period (48 h in most experiments), and area between the control growth curve and the time-kill curve from zero point to t-ABBC) were examined with daptomycin (DAP)- and vancomycin (VAN)-exposed Staphylococcus aureus. To compare the pharmacodynamics of DAP and VAN and examine different parameters, killing kinetics of differentially susceptible S. aureus were studied over a wide range of ratios of area under the curve (AUC) to MIC. Killing kinetics of two clinical isolates, S. aureus 866 (MIC(DAP) 0.35 mg/L and MIC(VAN) 0.70 mg/L) and S. aureus 10 (MIC(DAP) 1.1mg/L and MIC(VAN) 1.3mg/L), were studied in an in vitro dynamic model that simulates human pharmacokinetics of DAP (as a single dose) and VAN (as two 12-h doses). Mono-exponential concentration decays were mimicked with half-lives of 9h (DAP) and 6h (VAN) at AUC/MIC ratios varying from 33 to 1150 h. T(90%), T(99%) and N(t) (at t=48 h) exhibited loose, if any, correlations with log AUC/MIC. Both ABBC (a direct measure of the antimicrobial effect) and N(min) (an inverse measure of the effect) correlated well with log AUC/MIC (r(2)=0.8-0.9). Based on the ABBC-log AUC/MIC relationships, the effects of DAP on S. aureus were predicted to be slightly greater than those of VAN at a given AUC/MIC ratio. The better abilities of ABBC and N(min) and the inability of T(90%) and T(99%) to provide reasonable AUC/MIC relationships with DAP and VAN support earlier findings reported with fluoroquinolones.

摘要

仅在氟喹诺酮类药物的体外研究中比较了不同细菌杀灭指标确保合理浓度-反应关系的能力。为确定这些研究得出的结论与其他抗生素类别的相关性,对反映初始杀灭速率(分别将初始接种物减少10倍和100倍的时间——T(90%)和T(99%))、杀灭程度(存活生物体的最小数量——N(min))以及整个抗菌效果(在接近观察期结束时(大多数实验中为48小时)时间t时存活生物体的数量(N(t))以及从零点到t的对照生长曲线与时间-杀灭曲线之间的面积——ABBC)的五个广泛使用的指标,用达托霉素(DAP)和万古霉素(VAN)处理金黄色葡萄球菌进行了研究。为比较DAP和VAN的药效学并检查不同参数,在曲线下面积(AUC)与最低抑菌浓度(MIC)的广泛比例范围内研究了不同敏感性金黄色葡萄球菌的杀灭动力学。在一个模拟DAP(单剂量)和VAN(两剂12小时剂量)人体药代动力学的体外动态模型中,研究了两种临床分离株金黄色葡萄球菌866(MIC(DAP) 0.35 mg/L和MIC(VAN) 0.70 mg/L)和金黄色葡萄球菌10(MIC(DAP) 1.1mg/L和MIC(VAN) 1.3mg/L)的杀灭动力学。在AUC/MIC比值从33到1150小时变化时,模拟了半衰期为9小时(DAP)和6小时(VAN)的单指数浓度衰减。T(90%)、T(99%)和N(t)(在t = 48小时时)与log AUC/MIC呈松散(如果有的话)相关性。ABBC(抗菌效果的直接测量指标)和N(min)(效果的反向测量指标)均与log AUC/MIC有良好相关性(r(2)=0.8 - 0.9)。基于ABBC - log AUC/MIC关系,在给定的AUC/MIC比值下,预计DAP对金黄色葡萄球菌的作用略大于VAN。ABBC和N(min)的较好能力以及T(90%)和T(99%)无法与DAP和VAN建立合理的AUC/MIC关系,支持了先前关于氟喹诺酮类药物的研究结果。

相似文献

1
Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.浓度-效应关系作为选择抗菌作用最佳终点的依据:达托霉素和万古霉素在体外动态模型中对葡萄球菌的药效学研究
Int J Antimicrob Agents. 2007 Feb;29(2):165-9. doi: 10.1016/j.ijantimicag.2006.09.011. Epub 2007 Jan 4.
2
Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.在体外动态模型中,用暴露于达托霉素和万古霉素的金黄色葡萄球菌检验突变选择窗假说。
J Antimicrob Chemother. 2006 Dec;58(6):1185-92. doi: 10.1093/jac/dkl387. Epub 2006 Oct 5.
3
Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.替考拉宁和万古霉素在体外动态模型中对金黄色葡萄球菌的药效学研究
J Antimicrob Chemother. 2008 Nov;62(5):1065-9. doi: 10.1093/jac/dkn288. Epub 2008 Jul 17.
4
ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model.ABT492与左氧氟沙星:在体外动态模型中它们的药效学及其预防耐甲氧西林金黄色葡萄球菌产生的能力比较
J Antimicrob Chemother. 2004 Jul;54(1):178-86. doi: 10.1093/jac/dkh242. Epub 2004 Jun 9.
5
Linezolid pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.利奈唑胺在体外动态模型中对金黄色葡萄球菌的药效学研究
Int J Antimicrob Agents. 2009 Mar;33(3):251-4. doi: 10.1016/j.ijantimicag.2008.09.006. Epub 2008 Dec 17.
6
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).亚太地区革兰氏阳性菌分离株的抗菌药敏性以及达托霉素、万古霉素和替考拉宁杀菌活性的体外评估:哨兵计划报告(2003 - 2004年)
Int J Antimicrob Agents. 2007 Aug;30(2):143-9. doi: 10.1016/j.ijantimicag.2007.03.015. Epub 2007 May 24.
7
Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system.在体外药代动力学系统中研究达巴万星的药效学。
J Antimicrob Chemother. 2006 Oct;58(4):802-5. doi: 10.1093/jac/dkl311. Epub 2006 Aug 5.
8
Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.比较达托霉素、万古霉素和替考拉宁在感染的体外药代动力学模型中的抗菌效果。
J Antimicrob Chemother. 2009 Nov;64(5):1044-51. doi: 10.1093/jac/dkp289. Epub 2009 Sep 16.
9
Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.在生理白蛋白浓度存在的情况下,模拟达托霉素和万古霉素的血清浓度在治疗的前 24 小时内对万古霉素敏感、耐受或中介耐药金黄色葡萄球菌的活性。
Int J Antimicrob Agents. 2011 Apr;37(4):332-8. doi: 10.1016/j.ijantimicag.2010.12.007.
10
Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model.新型氟喹诺酮类药物ABT492与左氧氟沙星在体外动态模型中对肺炎链球菌的比较药效学研究
Int J Antimicrob Agents. 2005 May;25(5):409-13. doi: 10.1016/j.ijantimicag.2005.02.004.

引用本文的文献

1
Correlations of vancomycin trough concentration and its efficacy and toxicity in patients in the intensive care unit.重症监护病房患者万古霉素谷浓度与其疗效和毒性的相关性。
World J Clin Cases. 2025 Jun 6;13(16):102866. doi: 10.12998/wjcc.v13.i16.102866.
2
Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.基于群体药代动力学模型的新生儿及婴儿万古霉素合理给药算法研究
Antimicrob Agents Chemother. 2015 Dec 7;60(2):1013-21. doi: 10.1128/AAC.01968-15. Print 2016 Feb.